Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Arginine Hydrochloride in Anemia, Sickle Cell: NCT04839354 Clinical Landscape Report 2026
16 October 2026
NCT04839354 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Enoxacin in Amyotrophic Lateral Sclerosis: NCT04840823 Clinical Landscape Report 2026
16 October 2026
NCT04840823 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Piperaquine tetraphosphate/Artenimol in Malaria: NCT04844099 Clinical Landscape Report 2026
16 October 2026
NCT04844099 clinical landscape for Malaria: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant human coagulation factor VIII-Fc fusion protein (Gensciences) in Hemophilia A: NCT04845399 Clinical Landscape Report 2026
16 October 2026
NCT04845399 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rurioctocog alfa pegol in Hemophilia A: CTRI/2021/04/032837 Clinical Landscape Report 2026
16 October 2026
CTRI/2021/04/032837 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Renizgamglogene autogedtemcel in Anemia, Sickle Cell: NCT04853576 Clinical Landscape Report 2026
16 October 2026
NCT04853576 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
L-Citrulline in Arterial Occlusive Diseases: NCT04852172 Clinical Landscape Report 2026
16 October 2026
NCT04852172 clinical landscape for Arterial Occlusive Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lanifibranor in Metabolic Dysfunction Associated Steatohepatitis: NCT04849728 Clinical Landscape Report 2026
16 October 2026
NCT04849728 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Marstacimab-hncq in Hemophilia: NCT04878731 Clinical Landscape Report 2026
16 October 2026
NCT04878731 clinical landscape for Hemophilia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tofersen in Amyotrophic Lateral Sclerosis 1: NCT04856982 Clinical Landscape Report 2026
16 October 2026
NCT04856982 clinical landscape for Amyotrophic Lateral Sclerosis 1: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant Human Coagulation Factor VIII (Takeda) in Hemophilia A: NCT04864743 Clinical Landscape Report 2026
16 October 2026
NCT04864743 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HU-6 in Metabolic Dysfunction Associated Steatohepatitis: NCT04874233 Clinical Landscape Report 2026
16 October 2026
NCT04874233 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…